Today, sepsis continues to be a growing problem in the critically ill patient population. A number of laboratories have been interested in understanding how changes in immune cell apoptosis during sepsis appear to contribute to septic morbidity. Consistently, it has been found that immune cell apoptosis is altered in a variety of tissue sites and cell populations both in experimental animals and humans. While divergent mediators, such as steroids and TNF, contribute to some of these apoptotic changes, their effects are tissue and cell population selective. Inhibition of FasL—Fas signaling (by either FasL gene deficiency, in vivo gene silencing [siRNA] or with FasL binding protein) protects septic mice from the onset of marked apoptosis and the morbidity/mortality seen in sepsis. Further, this extrinsic apoptosis response appears to utilize aspects of the Bid-induced mitochondrial pathway. This is in keeping with the findings that pan-specific caspase inhibition or the overexpression of Bcl-2 also protect these animals from the sequellae of sepsis.
Angus DC, Linde-Zwirble WT, Lidicker J., Clermont G., Carcillo J., Pinsky MREpidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med2001; 29: 1303—1310.
2.
Szabo G., Romics L., Frendl G.Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis2004; 6: 1045—1066.
3.
Chaudry IH, Ayala A., Singh G., Wang P., Hauptman JGRodent models of endotoxemia and sepsis. In: Schlag G, Redl H. (eds) Pathophysiology of Shock, Sepsis and Organ Failure. Berlin : Springer, 1993; 1048—1059.
4.
Chaudry IH, Wichterman KA, Baue AEEffect of sepsis on tissue adenine nucleotide levels. Surgery1979; 85: 205—211.
5.
Wichterman KA , Baue AE, Chaudry IHSepsis and septic shock — a review of laboratory models and a proposal. J Surg Res1980; 29: 189—201.
6.
Meakins JL, Pietsch JB, Bubenick O., Kelly R., Rode H., Gordon J., MacLean LD. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg1977 ; 186: 241—250.
7.
Pietsch JB, Meakins JL, MacLean LD. The delayed hypersensitivity response: application in clinical surgery. Surgery1977; 82: 349—355.
8.
Ayala A., Lomas JL, Grutkoski PS, Chung CSPathological aspects of apoptosis in severe sepsis and shock?Int J Biochem Cell Biol2003; 35: 7—15.
9.
Oberholzer C. , Oberholzer A., Clare-Salzler M., Moldawer LLApoptosis in sepsis: a new target for therapeutic exploration. FASEB J2001; 15: 879—892.
10.
Chung CS, Song GY, Lomas J., Simms HH, Chaudry IH, Ayala A.Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol2003; 74: 344—351.
11.
Chung CS, Yang SL, Song GY et al. Inhibition of Fas signaling prevents hepatic injury and improves organ blood flow. Surgery2001; 130: 339—345.
12.
Ayala A., Evans TA, Chaudry IHDoes hepatocellular injury in sepsis involve apoptosis?J Surg Res1998; 76: 165—173.
13.
Hotchkiss RS , Swanson PE, Freeman BD et al. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med1999; 27: 1230—1251.
14.
Roth E., Hanspeter P.IFN-γ promotes Fas ligand-and perforinmediated liver cell destruction by cytotoxic CD8 T cells. J Immunol2004; 172: 1588—1594.
15.
Krammer PHCD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol1999; 71: 163—210.
16.
Janeway Jr CAHow the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci USA2004; 98: 7461—7468.
17.
Krammer PHCD95's deadly mission in the immune system. Nature2000; 407: 789—795.
18.
Chung CS, Xu YX, Wang W., Chaudry IH, Ayala A.Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis?Arch Surg1998; 133: 1213—1220.
19.
Angus DC, Wax RSEpidemiology of sepsis: an update. Crit Care Med2001; 29: S109-S116.
20.
Martin GS, Mannino DM, Eaton S., Moss M.The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med2003; 348: 1546—1554.
21.
Alberti C., Brun-Buisson C., Burchardi H. et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med2002; 28: 108—121.
22.
Chung CS, Xu YX, Wang W., Chaudry IH, Ayala A.Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis?Arch Surg1998; 133: 1213—1220.
23.
Hotchkiss RS , Swanson PE, Knudson CM et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol1999; 162: 4148—4156.
24.
Ayala A., Herdon CD, Lehman DL, Ayala CA, Chaudry IHDifferential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood1996; 87: 4261—4275.
25.
Chung CS, Song GY, Lomas J., Simms HH, Chaudry IH, Ayala A.Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol2003; 74: 344—351.
26.
Wesche-Soldato DE, Chung CS, Lomas-Neira J., Doughty LA, Gregory SH, Ayala A.In vivo delivery of caspase 8 or Fas siRNA improves the survival of septic mice. Blood2005; 106: 2295—2301.
27.
Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IEAccelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathway. J Immunol2005; 174: 5110—5118.
28.
Hotchkiss RS, Chang KC, Swanson PE et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol2001; 1: 496—501.
29.
Mahidhara R., Billiar T.Apoptosis in sepsis. Crit Care Med2000; 28: N105—N113.
30.
Hotchkiss RS, Swanson PE, Freeman BD et al. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med1999; 27: 1230—1251.
31.
Coopersmith CM, Stromberg PE, Dunne WM et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA2002; 287: 1716—1721.
32.
Coopersmith CM, Chang KC, Swanson PE et al. Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med2002; 30: 195—201.
33.
Hotchkiss R. , Karl IEEndothelial cell apoptosis in sepsis: a case of habeas corpus?Crit Care Med2004; 32: 901—902.
34.
Mutunga M., Fulton B., Bullock R. et al. Circulating endothelial cells in patients with septic shock . Am J Respir Crit Care Med2001; 163: 195—200.
35.
Miniagar A. , Jy W., Jimenez JJ et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology2001; 56: 1319—1324.
36.
Zhou M., Simms HH, Wang P.Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann Surg2004; 240: 321—330.
37.
Chung CS, Chaudry IH, Ayala A.The apoptotic response of the lymphoid immune system to trauma, shock and sepsis. In: Vincent J-L. (ed): Yearbook of Intensive Care and Emergency Medicine: 2000. Berlin: Springer, 2000; 27—40.
38.
Ayala A., Xu YX, Chung CS, Chaudry IHDoes Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis?Shock1999; 11: 211—217.
39.
Chung CS, Wang W., Chaudry IH, Ayala A.Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am J Physiol2001; 280: G812—G818.
40.
Fisher Jr CJ , Agosti JM, Opal SM et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med1996; 334: 1697—1702.
41.
Tannahill CL , Fukuzuka K., Marum T. et al. Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial peritonitis and endotoxemic shock . Surgery1999; 126: 349—357.
42.
De Freitas L, Fernandez-Somoza M., Essenfeld-Sekler E., Cardier JESerum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-1 receptor and FAS/FASL in sepsis. Chest2004; 125, 2238—2246.
43.
Docke WD, Randow F., Syrbe U. et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med1997; 3: 678—681.
44.
Hotchkiss RS , Chang KC, Grayson MH et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA2003; 100: 6724—6729.
45.
Mahidhara R. , Billiar T.Apoptosis in sepsis. Crit Care Med2000; 28: N105—N113.
46.
Bommhardt U. , Chang KC, Swanson PE et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol2004; 172: 7583—7591.
47.
Hotchkiss RS , Swanson PE, Knudson CM et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol1999; 162: 4148—4156.
48.
Iwata A., Stevenson VM, Minard A. et al. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol2003; 171: 3136—3141.
49.
Efron P., Moldawer LLSepsis and the dendritic cell. Shock2003; 20: 386—401.
50.
Ding Y., Chung CS, Newton S. et al. Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock2004; 22: 137—144.
51.
Efron PA, Martins A., Minnich D. et al. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol2004; 173: 3035—3043.
52.
Iwai K., Miyawaki T., Takizawa T. et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood1994; 84: 1201—1208.
53.
Fadeel B., Ahlin A., Henter JI, Orrenius S., Hampton MBInvolvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood1998; 92: 4808—4818.
54.
Murray J., Barbara JA, Dunkley SA et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood1997; 90: 2772—2783.
55.
Yamashita K. , Takahashi A., Kobayashi S. et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood1999; 93: 674—685.
56.
Renshaw SA, Parmar JS, Singleton V. et al. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol2003; 170: 1027—1033.
57.
Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A.Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood1992; 80: 2012—2020.
58.
Leuenroth SJ , Isaacson E., Lee C., Keeping H., Simms HHIntegrin regulation of polymorphonuclear leukocyte apoxis during hypoxia is primarily dependent on very late activation antigens 3 and 5. Surgery1997; 122: 153—162.
59.
Sweeney JF, Nguyen PK, Omann GM, Hinshaw DBUltraviolet irradiation accelerates apoptosis in human polymorphonuclear leukocytes: protection by LPS and GM-CSF. J Leukoc Biol1997; 62: 517—523.
60.
Niwa M., Hara A., Kanamori Y. et al. Comparison of susceptibility to apoptosis induced by rhTNFalpha and cycloheximide between human circulating and exudated neutrophils. Life Sci1997; 61: 205—215.
61.
Cox G., Austin RCDexamethasone-induced suppression of apoptosis in human neutrophils requires continuous stimulation of new protein synthesis. J Leukoc Biol1997; 61: 224—230.
62.
Ertel W., Keel M., Infanger M., Steckholzer U.,. Trentz O.Circulating mediators in serum of injured patients with septic complications inhibit apoptosis through up-regulation of protein-tyrosine phosphorylation . J Trauma1998; 44: 767—775.
63.
Watson WG, Rotstein OD, Paraodo J. et al. Impaired apoptotic death signaling in inflammatory lung neutrophils is associated with decreased expression of interleukin-1 beta converting enzyme family proteases (caspases). Surgery1997; 122: 163—172.
64.
Dunican AL, Leuenroth SJ, Grutkoski P., Ayala A., Simms HHTNF-α induced suppression of PMN apoptosis is mediated through IL-8 production . Shock2000; 14: 284—289.
65.
Grutkoski PS , D'Amico R., Ayala A., Simms HHIL-1beta stimulation induces paracrine regulation of PMN function and apoptosis. Shock1999; 12: 373—381.
66.
Goodman ER, Stricker P., Velavicius M. et al. Role of granulocyte-macrophage colony-stimulating factor and its receptor in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch Surg1999; 134: 1049—1054.
67.
Goodman ER, Kleinstein E., Fusco AM et al. Role of interleukin 8 in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch Surg1998; 133: 1234—1239.
68.
Taneja R., Parodo J., Jia SH, Kapus A., Rotstein ODDelayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med2004; 32: 1460—1469.
69.
Biffl WL, Moore EE, Moore FA, Barnett Jr CCInterleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma1996; 40: 575—579.
70.
Biffl WL, Moore EE, Moore FA, Carl VA, Peterson VMInterleukin-6 delays neutrophil apoptosis. Arch Surg1996; 131: 24—29.
71.
Leuenroth SJ , Lee C., Grutkoski PS, Keeping H., Simms HHInterleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions . Surgery1998; 124: 409—417.
72.
Dunican AL, Grutkoski PS, Leuenroth SJ, Ayala A., Simms HHNeutrophils regulate their own apoptosis via preservation of CXC receptors . J Surg Res2000; 90: 32—38.
73.
Haslett C.Resolution of acute inflammation and the role of apoptosis in the tissue. Clin Sci Colch1992; 83: 639—648.
74.
Liles WC, Klebanoff SJRegulation of apoptosis in neutrophils — Fas track to death?J Immunol1995; 154: 3289—3291.
75.
Ayala A., Chung CS, Lomas JL et al. Shock induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol2002; 161: 2283—2294.
76.
Matsui K., Fine A., Zhu B., Marshak-Rothstein A., Ju STIdentification of two NF-kappaB sites in mouse CD95 ligand (Fas ligand) promotor: functional analysis in T cell hybridoma. J Immunol1998; 161: 3469—3473.
77.
Jimenez MF, Watson WG, Parodo J. et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg1997; 132: 1263—1270.
78.
Matute-Bello J., Liles WC, Radella II F. et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med1997; 156: 1969—1977.
79.
Jia SH, Li Y., Parodo J. et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest2004; 113: 1318—1327.
80.
Ayala A., Karr SM, Evans TA, Chaudry IHFactors responsible for peritoneal granulocyte apoptosis during sepsis. J Surg Res1997; 69: 67—75.
81.
Arroyo A., Modriansky M., Serinkan FB et al. NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance. J Biol Chem2002; 277: 49965—49975.
82.
Wang P., Chaudry IHMechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol1996; 270: R927—R938.
83.
Chaudry IH, Schleck S., Clemens MG, Kupper TE, Baue AEAltered hepatocellular active transport. An early change in peritonitis. Arch Surg1982; 117: 151—157.
84.
Song E., Lee S-K., Wang J. et al. RNA interference targeting Fas protects mice from fulminant hepatitis . Nat Med2003; 9: 347—351.
85.
Hotchkiss RS , Chang KC, Swanson PE et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol2001; 1: 496—501.
86.
Weaver Jgr, Rouse MR, Steckelburg JM, Badley AMImproved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J2004; 18: 1185—1191.
